Tribune Therapeutics spins out from SPARK Norway

A SPARK Norway project led by researchers Ole Jørgen Kaasbøll and Håvard Attramadal forms the basis of a new startup company, Tribune Therapeutics, focused on fibrosis. Dr. Kaasbøll, who led the SPARK project, will become Chief Scientific Officer at Tribune. Dr. Kaasbøll and Dr. Attramadal are both researchers at Institute of Clinical Medicine, University of […]

SPARK Japan receives patent award

Research Studio powered by SPARK, the SPARK Japan program headquartered at University of Tsukuba, was recently awarded the IP BASE Award from the Japan Patent Office. Research Studio won the 2nd IP BASE Award for Ecosystem development along with Zero One Booster Inc., an accelerator. The Ecosystem award is given to communities or organizations who […]

SPARK Africa co-director identified new SARS-CoV-2 variant in South Africa

In December, two new variants of the SARS-CoV-2 virus were identified in the U.K. and in South Africa. Characterized by more accumulated mutations than other SARS-CoV-2 lineages, the two variants appeared to dominate over other versions of SARS-CoV-2. SPARK Africa co-director Prof. Tulio de Oliveira has been at the forefront of investigating the new South […]

Prof. Collen Masimirembwa to chair Pharmacogenomics Research Network committee

Prof. Collen Masimirembwa, director of SPARK GLOBAL Africa, has been appointed chair of the Developing Countries Committee at the Pharmacogenomics Research Network. Prof. Masimirembwa is President and CEO of the African Institute of Biomedical Science and Technology (AIBST) in Zimbabwe, and is a Distinguished Professor at the Sydney Brenner Institute for Molecular Bioscience (SBIMB) at […]